Is high-dose glucocorticoid beneficial in COVID-19?
- PMID: 33509962
- PMCID: PMC7842156
- DOI: 10.1183/13993003.00065-2021
Is high-dose glucocorticoid beneficial in COVID-19?
Abstract
High-dose glucocorticoids are not currently recommended for treating severe COVID-19 pneumonia
Conflict of interest statement
Conflict of interest: V. Muthu has nothing to disclose. Conflict of interest: I.S. Sehgal has nothing to disclose. Conflict of interest: K.T. Prasad has nothing to disclose. Conflict of interest: R. Agarwal has nothing to disclose.
Comment on
-
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.Eur Respir J. 2020 Dec 24;56(6):2002808. doi: 10.1183/13993003.02808-2020. Print 2020 Dec. Eur Respir J. 2020. PMID: 32943404 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical